共 7 条
- [3] Comment on: “Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation” [J]. PharmacoEconomics, 2017, 35 : 603 - 604
- [5] Authors’ Reply to Gandjour: “Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation” [J]. PharmacoEconomics, 2017, 35 : 605 - 606